zepbound retatrutide vs. Zepbound: How Does Lilly's Next-Gen Obesity Drug Compare to Tirzepatide? Zepbound vs Retatrutide: Which Weight

protect from heat and light State Appearance Storage Should stay clear

The TRIUMPH-4 Phase 3 trial showed 28.7% average weight loss with retatrutide 12 mg at 68 weeks, compared to 14.9% to 17.4% with semaglutide 2.4 mg across STEP trials

Return of appetite Retatrutide regulates appetite, feelings of fullness, and gastric emptying

Coverage for obesity indications (Wegovy, Saxenda, Zepbound) remains more limited

One trial showed an 11% decrease in LDL from baseline in participants taking pantethine

Other factors such as strenuous exercises or consumption of certain medication may also reduce the CoQ10 level in the body